@docroham

Professor of Medicine ; Director Adult Pulmonary Hypertension Program ; Associate Director Vera Moulton Wall Center; clinical trialist ; photographer.

 Stanford University
wallcenter.stanford.edu
Joined September 2012
  • Tweets650
  • Following613
  • Followers1K
134Media
Excited to have been part of a superb Phase 2 study of Seralutinib in PAH. Read it below: sciencedirect.com/science/ar…
1
3
14
853
Incredible. Hats off to all scientists/investigators/patients(!). Excited to have access to therapy w such a potential. BUT!!!! Inaccurate& misleading news will NOT help our field or patients. Opinion is not fact! @PVRI @Viniciodjperez @AlbertaPHdoc cnn.com/2024/03/26/health/wi…

FDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time...

When doctors told Katrina Barry that she had a rare and serious condition called pulmonary arterial hypertension, or PAH, they warned her not to Google it.

cnn.com
2
1
18
3,429
A pleasure to help pave to define disease modification in PAH. An honor to work with a superb group of colleagues - Exciting think-tank style collab, along with the ever-so-important patient perspective pubmed.ncbi.nlm.nih.gov/3847… @PHatStanford @AlbertaPHdoc @PVRI

Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension - PubMed

Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension

pubmed.ncbi.nlm.nih.gov
Vinicio de Jesus Perez, MD FAHA FCCP ATSF@Viniciodjperez12 Mar 2024
Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.
5
13
1,435
Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.
Jason Weatherald MD@AlbertaPHdoc12 Mar 2024
What does “disease modification” mean in #PulmonaryArterialHypertension? Honoured to be part of this perspective in @ATSBlueEditor led by @Viniciodjperez & @docroham atsjournals.org/doi/abs/10.1… @VApccm @BogaardHarm @mpsotka @PHACanada @PHAssociation @PVRI @UAlberta_DoM

American Thoracic Society Journals

American Thoracic Society Journals

academic.oup.com
1
4
1
8
2,874
Difficult news to hear….a huge loss for the field and our community. On behalf of @PHatStanford, our deepest condolences to the Newman family and Vanderbilt colleagues. His legacy will live on thru his contributions to our field and the many he has mentored.
The Pulmonary Vascular Research Institute
@PVRI21 Feb 2024
The PVRI is deeply saddened by the loss of Dr John Newman, a cherished member of the Pulmonary Vascular Disease community. His dedication and expertise have left an indelible mark on our field. Sending heartfelt condolences to his loved ones and colleagues during this time.
1
10
680
RIP Major Brian Shul! Incredible story of an aviator. - resilience, courage, and grit. Spoke at our @PHatStanford pulmonary hypertension symposium a few years ago…. nytimes.com/2023/05/30/us/br…

Brian Shul Dies at 75; Fighter Pilot Who Flew World’s Fastest Plane (Gift Article)

He was near death after his plane was shot down in the Vietnam War but survived to fly the world’s fastest and highest-altitude jet.

nytimes.com
1
3
358
Social hour at ATS with Stanford PH team & friends @StanfordPACCM @PHatStanford
2
2
38
1,667
Dr Andrew Sweatt - The Jane Moris Award recipient @ATS_PC Congratulations Andy!!!!!! Made us proud. @StanfordPACCM @PHatStanford
1
25
796
Congratulations to Andy Sweatt & Adam Andruska for amazing presentations on vasoreactivity in PAH & PVOD risk score. Did us proud!! @ATS_PC @atscommunity @StanfordPACCM
1
14
625
1
5
553
Replying to @docroham
@docroham Thanks for the invitation and wonderful discussions. #DIPH #Stanford
1
2
6
403
DIPH Symposium PVOD induced by alkylating agents & solvents by Prof Humbert @Inserm @PHatStanford @StanfordPACCM
3
15
663
Replying to @OSitbon
@OSitbon discusses the approach to Dasatinib-associated PAH at the @Stanford Drug Induced PH symposium 1️⃣Stop the drug! 2/3 will resolve with discontinuation alone 2️⃣Treatment based on risk/severity. @docroham @Viniciodjperez @pvri
5
2
15
1,835
More pics from the Drug-induced PH streaming NOW at Stanford.
1
16
601
Kicking off the @Stanford Drug Induced #PulmonaryHypertension symposium Fantastic lineup ahead. Thanks to @docroham for the invitation #DIPH @PHatStanford
1
4
1
21
2,026
DIPH 2023 @StanfordPACCM @PHatStanford
2
1
9
421
Lang先生によるcardio-oncologyのレクチャーです #DIPH #Stanford
1
5
468
Roham Zamanian retweeted
Montani David@Montanidavid14 Apr 2023
Happy to discuss genetics in drugs-associated PAH at @Stanford University. Thanks to @docroham for the invitation #DIPH @PHatStanford @pulmotension @RespiFIL @InsermU999 – at Stanford, CA
2
3
16
785
Second day of DIPH Symposium 2023 starts at 8 am PST. First day was amazing, 2nd will be exciting. Join us! livestream.com/accounts/1973… Or youtube.com/live/j54HG3dBTgU…
1
13
664
Drug Induced Pulmonary Hypertension Symposium at Stanford is 1 week away! HYBRID (In person & Live Streaming). Not too late to join us. Registration is still open. @PHatStanford @StanfordPACCM @StanfordDeptMed
6
15
1,200
Load more